Funding for this research was provided by:
National Natural Science Foundation of China (81873851)
National Key Research and Development Project of China (2016YFC1000307-17)
Received: 5 October 2019
Accepted: 18 February 2020
First Online: 3 March 2020
Ethics approval and consent to participate
: This study was approved by the Committee on Ethics of Xiangya Hospital of Central South University (NO: 201908299) and was performed in accordance with the Declaration of Helsinki.
: Written informed consent was obtained from the patient’s parents for publication of the clinical and molecular data.
: The authors declare that they have no competing interests.